These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31822108)

  • 1. Theory and practice of pharmacopoeial control of quality of drugs and excipients X. Number of parallel determinations, processing of results and their use in the assessment of the content of active substances and excipients in the European Pharmacopoeia (Ph. Eur.).
    Šubert J; Kolář J
    Ceska Slov Farm; 2019; 68(4):157-160. PubMed ID: 31822108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theory and practice of pharmacopoeial control of quality of drugs and excipients IX. The problem of tolerance limits for the content of active substances and excipients in the European Pharmacopoeia (Ph. Eur.).
    Šubert J; Kolář J
    Ceska Slov Farm; 2019; 68(3):91-94. PubMed ID: 31431018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theory and practice of pharmacopoeial control of the quality of drugs and excipients VII. The colour reference solutions of the European pharmacopoeia (Ph. Eur.).
    Šubert J; Kolář J; Čižmárik J
    Ceska Slov Farm; 2018; 67(1):30-31. PubMed ID: 30157665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theory and practice of pharmacopoeial control of quality of drugs and excipients VIII. End-point indication and other conditions for the titration of primary aromatic amines in the European Pharmacopoeia (Ph. Eur.).
    Šubert J; Kolář J
    Ceska Slov Farm; 2019; 68(1):34-36. PubMed ID: 31163965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and international harmonization of pharmacopoeial standards.
    Calam DH
    J Pharm Biomed Anal; 1995 Dec; 14(1-2):1-5. PubMed ID: 8833960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Microbiological and biological methods of the European Pharmacopoeia. Relevant for each medicinal product].
    Norwig J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1158-68. PubMed ID: 25200487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Excipients: regulatory aspects].
    Artiges A
    Therapie; 1999; 54(1):15-9. PubMed ID: 10216417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ingredients in pharmaceutical preparations: a problem not value.
    Lubner GC
    Boll Chim Farm; 2002; 141(5):332. PubMed ID: 12481372
    [No Abstract]   [Full Text] [Related]  

  • 9. Uniformity of weight test: a non-destructive test compared to the European Pharmacopoeia test.
    Hoppe-Tichy T; Fiederling J; Trippe ZA
    Pharmazie; 2008 Jul; 63(7):508-10. PubMed ID: 18717483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiological quality of pharmaceutical raw materials.
    de la Rosa MC; Medina MR; Vivar C
    Pharm Acta Helv; 1995 Sep; 70(3):227-32. PubMed ID: 7480068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control of aromatic drugs reported in European Pharmacopoeia 3rd edition.
    Miraldi E; Giachetti D; Ferri S
    Farmaco; 2001; 56(5-7):365-71. PubMed ID: 11482760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chromatographic methods in the European Pharmacopoeia].
    Ráfliné RZ; Kószeginé SH; Török I; Paál T
    Acta Pharm Hung; 2001 Aug; 71(2):205-12. PubMed ID: 11862671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Note on the measurement of flowability according to the European Pharmacopoeia.
    Schüssele A; Bauer-Brandl A
    Int J Pharm; 2003 May; 257(1-2):301-4. PubMed ID: 12711185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calibration of human coagulation factor VIII concentrate Ph. Eur. BRP Batch 4 for use in potency assays.
    Raut S; Costanzo A; Daniels S; Heath A; Buchheit KH
    Pharmeur Bio Sci Notes; 2010 Oct; 2010(2):1-29. PubMed ID: 21144486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacopoeia as quality codex for the manufacturers.
    Soldi A
    Ann Ist Super Sanita; 1975; 11(3-4):269-80. PubMed ID: 1234728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of reference substances in pharmacopoeia specifications.
    Johnson CA
    Ann Ist Super Sanita; 1975; 11(3-4):314-21. PubMed ID: 1234733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the use of instrumental measurement of colour in the development, production and quality control of drugs, medicinal preparations and pharmaceutical auxiliary substances III.
    Šubert J; Čižmárik J; Kolář J
    Ceska Slov Farm; 2020; 69(2):59-66. PubMed ID: 32545984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacopeia and preparations for cutaneous application].
    Esnault F; Etchegaray JP; Mallard C
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714
    [No Abstract]   [Full Text] [Related]  

  • 20. Compliance of scored tablet halves produced by Palestinian Pharmaceutical Companies with the new European Pharmacopoeia requirements.
    Zaid AN; Ghosh AA
    Arch Pharm Res; 2011 Jul; 34(7):1183-9. PubMed ID: 21811926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.